B&K Corp-B 02396
IPOIPO Allotment Results Analysis
3.5009.37%( +0.300 )
Nov 13 · End-of-day data, not live · Hong Kong Stock Exchange
Allotment Results · 20251222
IPOIPO Allotment Results Analysis| Rank | % of international placing | % of global offering |
|---|---|---|
| Top 5 | 33.98% | 30.58% |
| Top 10 | 51.23% | 46.11% |
| Top 25 | 78.87% | 70.98% |
华芢生物－Ｂ IPO attracted overwhelming retail demand, with an oversubscription ratio of 791.95 times, leading to a low hit rate of just 5.44%. This indicates fierce competition for allocations and strong market enthusiasm for this 18A biotech listing. (This is AI-generated commentary based on historical data. Past patterns do not guarantee future outcomes. Not financial advice.)
A notable tier allocation anomaly exists: 甲尾 (A-tail) applicants with 90,000 shares expected only 0.1375 lots, while 乙头 (B-head) applicants with 100,000 shares expected a significantly higher 0.6003 lots. This extreme disparity suggests that the allocation curve is highly convex at this boundary, making B-head applications disproportionately more efficient for those who can reach the threshold. (This is AI-generated commentary based on historical data. Past patterns do not guarantee future outcomes. Not financial advice.)
The applicant pool shows a strong mainland China presence at 64.2%, indicating high cross-border interest in this biotech IPO. Male investors dominate at 63.3%, with an average age of 45.2, consistent with typical HK IPO demographics but with a notably high mainland share. (This is AI-generated commentary based on historical data. Past patterns do not guarantee future outcomes. Not financial advice.)
This page shows allotment analysis for B&K Corp-B (02396): one-lot hit rate, Pool A/B allotment distribution, oversubscription multiple, and grey-market and first-day performance. Data is parsed from the HKEX allotment results announcement. How allotment rates and clawback work is explained in How Hong Kong IPO Allotment Rates Work.
